Akari Therapeutics, Plc (AKTX) Discusses New Patent Filing and Expansion of ADC Pipeline for Solid Tumors Transcript
Source: SeekingAlpha
2026-02-11 14:14:26 ET
Akari Therapeutics, Plc (AKTX) Discusses New Patent Filing and Expansion of ADC Pipeline for Solid Tumors February 10, 2026 7:00 PM EST...
Read the full article on Seeking Alpha
For further details see:
Akari Therapeutics, Plc (AKTX) Discusses New Patent Filing and Expansion of ADC Pipeline for Solid Tumors Transcript
Akari Therapeutics Plc
NASDAQ: AKTX
AKTX Trading
1.52% G/L:
$0.2539 Last:
116,219 Volume:
$0.2449 Open:
AKTX Latest News
February 26, 2026 09:10:00 am
Akari Therapeutics Appoints Leading Cancer Biology and RNA Expert, Prafulla Gokhale, Ph.D., to Scientific Advisory Board
February 23, 2026 08:50:00 am
Akari Therapeutics Appoints Globally Recognized Expert in RNA Biology and Cancer Research, Olga Anczukow, Ph.D., to its Scientific Advisory Board
February 18, 2026 09:05:00 am
Akari Therapeutics to Present at the 2026 Biocom Global Partnering & Investor Conference
AKTX Stock Data
$11,330,884
22,524,424
0.06%
9
N/A
Biotechnology & Life Sciences
Healthcare
GB
Tampa
